PHEnFX — Class II food recall F-2400-2014
Terminated recall by Beta Labs, reported 2014-09-03, distributed nationwide. The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is n
| Recall number | F-2400-2014 |
|---|---|
| Product type | Food |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Beta Labs, Memphis, TN, United States |
| Recall initiated | 2013-06-20 |
| Classified | 2014-08-27 |
| Reported by FDA | 2014-09-03 |
| Terminated | 2014-12-03 |
| Distributed | Nationwide (US) |
| Countries outside the US | GB |
| Quantity | 743 units |
| UPC / GTIN / UDI-DI | 00029882559802 |
| Lot numbers | 12/16, 1205129 |
Product
PHEnFX (TM), PHENO 550 mg, PHARMACEUTICAL GRADE, 90 CAPSULES, Manufactured for: Beta Labs, LTD, Newark, DE 19711, UPC 029882559802
Reason for recall
The products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine or geranium extract, which is not permitted in dietary supplements.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/F-2400-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.